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Shiga toxins have been shown to induce apoptosis in many cell types. However, Shiga toxin 1 (Stx1) induced
only limited apoptosis of macrophage-like THP-1 cells in vitro. The mechanisms regulating macrophage death
or survival following toxin challenge are unknown. Differentiated THP-1 cells expressed tumor necrosis factor
receptors and membrane-associated tumor necrosis factor alpha (TNF-) and produced soluble TNF- after
exposure to Stx1. However, the cells were refractory to apoptosis induced by TNF-, although the cytokine
modestly increased apoptosis in the presence of Stx1. Despite the partial resistance of macrophage-like THP-1
cells to Stx1-mediated killing, treatment of these cells with Stx1 activated a broad array of caspases, disrupted
the mitochondrial membrane potential (m), and released cytochrome c into the cytoplasm. The m values
were greatest in cells that had detached from plastic surfaces. Specific caspase inhibitors revealed that
caspase-3, caspase-6, caspase-8, and caspase-9 were primarily involved in apoptosis induction. The antiapop-
totic factors involved in macrophage survival following toxin challenge include inhibitors of apoptosis proteins
and X-linked inhibitor of apoptosis protein. NF-B and JNK mitogen-activated protein kinases (MAPKs)
appeared to activate survival pathways, while p38 MAPK was involved in proapoptotic signaling. The JNK and
p38 MAPKs were shown to be upstream signaling pathways which may regulate caspase activation. Finally, the
protein synthesis inhibitors Stx1 and anisomycin triggered limited apoptosis and prolonged JNK and p38
MAPK activation, while macrophage-like cells treated with cycloheximide remained viable and showed tran-
sient activation of MAPKs. Collectively, these data suggest that Stx1 activates both apoptotic and cell survival
signaling pathways in macrophage-like THP-1 cells.
Shiga toxins (Stxs) are structurally and functionally related
protein toxins expressed by Shigella dysenteriae serotype 1 and
certain serotypes of Escherichia coli. These bacteria are a se-
rious public health concern because they are capable of caus-
ing widespread outbreaks of bloody diarrhea in which a frac-
tion of patients subsequently develop life-threatening
complications, such as acute renal failure and neurological
abnormalities (41). The histopathological hallmark of disease
caused by Stxs is the destruction of blood vessels serving the
colon, kidneys (especially renal glomeruli), and central nervous
system (27). The toxins consist of a single enzymatic A subunit
in noncovalent association with a pentameric ring of glycolipid-
binding B subunits. Stxs which cause disease in humans bind
the neutral glycolipid globotriaosylceramide (Gb3). Once
bound to Gb3, holotoxin molecules are internalized and traf-
ficked to the endoplasmic reticulum through the Golgi appa-
ratus. In the transport process, the A subunit is cleaved, and
the A1 fragment is translocated into the cytosol. The A1 frag-
ment mediates protein synthesis inhibition through cleavage of
a single adenine residue in the 28S rRNA component of eu-
karyotic ribosomes (26). S. dysenteriae expresses the prototyp-
ical Shiga toxin, while toxin-producing E. coli may express one
or more toxins designated Shiga toxin type 1 (Stx1) or Stx2
based on their antigenic similarity to Shiga toxin (39).
Stxs kill epithelial cell lines (e.g., Vero cells) in vitro in pg/ml
quantities, and a concept that Stxs may directly target epithe-
lial and vascular endothelial cells for damage has emerged.
However, the role of the toxins in pathogenesis may be more
complex. Stxs elicit the expression of proinflammatory cyto-
kines and chemokines from epithelial cells (11, 43) and mac-
rophages (31, 46). The cytokines tumor necrosis factor alpha
(TNF-) and interleukin-1 sensitize endothelial cells to the
cytotoxic action of the toxins in vitro (32, 45) by upregulating
expression of enzymes involved in Gb3 biosynthesis (38). The
production of chemokines may account for the influx of in-
flammatory cells into sites where there is vascular damage and
the activation of platelets leading to the deposition of micro-
thrombi (6). Stxs also induce apoptosis in human epithelial,
endothelial, and myelomonocytic cell lines in vitro and in hu-
man and murine renal epithelial cells in vivo (2, 15). The toxins
may not activate a common apoptotic signaling pathway in all
cell types. Jones et al. (13) showed that Stxs induced apoptosis
in HEp-2 cells which was associated with increased expression
of the proapoptotic Bax protein and was blocked by a
caspase-3 inhibitor. Fujii et al. (5) showed that Stxs induced
apoptosis in HeLa cells that required the rapid activation of
caspase-6 and caspase-8, the cleavage of Bid, and the release of
cytochrome c from mitochondrial membranes. Stxs also ap-
peared to upregulate expression of the antiapoptotic protein
X-linked inhibitor of apoptosis protein (XIAP) in HeLa cells,
leading to inhibition of caspase-9 function. Induced expression
of the transfected stx1B gene in HeLa cells led to apoptosis,
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characterized by caspase-1 and -3 activation and DNA frag-
mentation, while expression of the transfected stx1A gene trig-
gered necrotic cell death characterized by increased lactate
dehydrogenase release and a lack of DNA laddering (25). In
Burkitt’s lymphoma cell lines, purified Stx1 or anti-Gb3 mono-
clonal antibody was capable of triggering apoptotic cell death
through mechanisms involving rapid activation of caspase-8,
followed by caspase-3 and caspase-7 activation (16). Finally,
TNF- is a well-characterized apoptosis inducer. It is unclear
whether Stxs directly activate apoptosis or indirectly activate
apoptosis through induction of TNF- expression.
We have demonstrated that there are differences in apop-
tosis induction in the myelogenous leukemia cell line THP-1
that are dependent on the state of cell maturation. Treatment
of undifferentiated, monocyte-like THP-1 cells with purified
Stx1 led to the rapid onset of apoptosis in the absence of
cytokine expression, resulting in approximately 85% cell death
in 12 h (7). Signaling for apoptosis in monocytic cells involved
the rapid activation of caspase-3, caspase-8, caspase-6, and
caspase-9, the cleavage of Bid, the disruption of mitochondrial
membrane potential, and the release of cytochrome c into the
cytosol. Apoptosis induction in monocytes required toxin en-
zymatic activity and was TNF- and tumor necrosis factor
receptor (TNFR) independent (17). Differentiation of THP-1
cells to the macrophage-like state was accompanied by the
ability to express soluble cytokines after treatment with Stxs
and a loss of sensitivity to Stx1-mediated apoptosis induction,
with only 11% cell death at 12 h and cell death peaking at
36% at 48 h (7). Furthermore, only in macrophage-like THP-1
cells was the transcriptional activator NF-B translocated to
the nucleus, and the JNK and p38 mitogen-activated protein
kinase (MAPK) pathways were activated for a prolonged time
after Stx1 stimulation (3, 34). Stxs and other protein synthesis
inhibitors that act on the peptidyltransferase center of eukary-
otic ribosomes induce the ribotoxic stress response through
activation of JNK and p38 MAPKs (3, 12, 37). It is known that
activation of NF-B induces expression of many antiapoptotic
proteins (14). Recent studies have demonstrated that p38
MAPK signaling induces a proapoptotic response, while acti-
vation of JNK induces either anti- or proapoptotic signaling
depending on the cell type (22, 37). The purpose of this study
was to better understand the different responses of monocytic
and macrophage-like THP-1 cells to Stxs. We found that in
contrast to the effect on toxin-sensitive monocytic cells, in
macrophage-like THP-1 cells Stx1 triggered NF-B- and JNK
MAPK-mediated antiapoptotic signals, resulting in prolonged
expression of inhibitor of apoptosis proteins (IAPs). Further-
more, Stx1 triggered the ribotoxic stress response only in mac-
rophage-like cells. Thus, the toxin appears to simultaneously
activate pro- and antiapoptotic signaling mechanisms in mac-
rophages.
MATERIALS AND METHODS
Cells. The human myelogenous leukemia cell line THP-1 (44) was purchased
from the American Type Culture Collection (Manassas, VA) and was main-
tained in RPMI 1640 medium (GibcoBRL, Grand Island, NY) supplemented
with 10% fetal bovine serum (FBS) (HyClone Laboratories, Logan, UT), peni-
cillin (50 g/ml), and streptomycin (50 g/ml) at 37°C in the presence of 5% CO2
in a humidified incubator. For differentiation to the macrophage-like state,
THP-1 cells (1  106 cells/ml) were treated with phorbol 12-myristate 13-acetate
(Sigma Chemical Co., St. Louis, MO) at a concentration of 50 ng/ml for 48 h.
Adherent, differentiated cells were washed with cold, sterile phosphate-buffered
saline (PBS) (Sigma) and incubated with medium lacking phorbol 12-myristate
13-acetate. The medium was changed every 24 h for 3 days. Cells were stimulated
with Stx1 at a concentration of 400 ng/ml, a concentration previously demon-
strated to induce JNK and p38 phosphorylation in differentiated THP-1 cells (3).
Reagents. Purified Stx1 was prepared by expression of the toxin operon from
recombinant strain E. coli DH5(pCKS112) (42). Crude bacterial lysates were
subjected to sequential ion-exchange, chromatofocusing, and immunoaffinity
chromatography procedures. Toxin purity was assessed by sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis (SDS-PAGE) with silver staining and by
Western blot analysis using bovine polyclonal antibodies directed against Stx1.
Purified Stx1 holotoxin containing a double mutation (E167Q, R170L) in the A
subunit which inactivates enzymatic activity (28) was a kind gift from Yoshifumi
Takeda, Cine-Science Laboratories, Tokyo, Japan. Purified toxin preparations
were determined to contain 0.1 ng of endotoxin per ml by the Limulus amoe-
bocyte lysate assay (Associates of Cape Cod, Inc., East Falmouth, MA). Recom-
binant human TNF- (rhTNF-), nonfluoresceinated monoclonal antibodies
directed against human membrane-bound TNF- (mTNF-) and TNFR1, and
fluorescein-conjugated antibodies directed against mTNF-, TNFR1, and
TNFR2 (for fluorescence-activating cell sorting [FACS] analysis) were pur-
chased from R&D Systems Inc., Minneapolis, MN. Murine immunoglobulin
(IgG) was obtained from Sigma. The caspase-1 inhibitor Z-Tyr-Val-Ala-Asp-
fmk, the caspase-2 inhibitor Z-Val-Asp-Val-Ala-Asp-fmk, the caspase-3 inhibi-
tor Z-Asp-Glu-Val-Asp-fmk, the caspase-6 inhibitor Z-Val-Glu-Ile-Asp-fmk, the
caspase-8 inhibitor Z-Ile-Glu-Thr-Asp-fmk, the caspase-9 inhibitor Z-Leu-Glu-
His-Asp-fmk, and the general caspase inhibitor N-benzyl-oxycarbonyl-Val-Ala-
Asp(OMe)-fluoromethyl-ketone (ZVAD-fmk) were purchased from Calbio-
chem, San Diego, CA. The concentrations of caspase inhibitors that optimally
inhibited specific caspase activities in the experiments were determined in pre-
vious studies (17). Antibodies directed against human caspase-3, caspase-8, and
caspase-9 were obtained from Cell Signaling Technology, Beverly, MA. The
NF-B inhibitor pyrrolidine dithiocarbamate, the JNK inhibitor SP600125, and
the p38 MAPK inhibitor SB203580 were purchased from Calbiochem. Anisomy-
cin and cycloheximide (CHX) were purchased from Sigma.
Analysis of cell surface receptor expression. Immunofluorescence staining for
TNFR1, TNFR2, and mTNF- was performed as previously described (17).
Briefly, macrophage-like THP-1 cells (5  106 cells/ml) were incubated with or
without Stx1 for 4 h. Following this treatment, cells were washed twice with cold
PBS, 3.0 ml of trypsin was added, and the preparations were incubated for 2 min
at 37°C in the presence of 5% CO2. Trypsinization was stopped by adding an
equal volume of medium, and supernatants were removed after centrifugation at
260  g for 5 min. Cells were fixed in 4% paraformaldehyde for 15 min on ice,
washed with PBS containing 0.5% bovine serum albumin, and incubated with
fluorescein-conjugated antibodies directed against human mTNF-, TNFR1, or
TNFR2 for 30 to 45 min on ice. After washing, membrane fluorescence was
measured by flow cytometry (FACSCalibur; Becton Dickinson, Palo Alto, CA);
1  104 cells were counted for each treatment. Untreated cells and cells treated
with fluorescein-conjugated mouse IgG were used as controls.
Analysis of apoptosis by the MTT assay. Differentiated THP-1 cells (1  105
cells/well) were plated in 96-well microtiter plates. Before Stx1 treatment, NF-B
(50 M), JNK (50 M), and p38 (20 M) inhibitors were added for 1 h prior to
stimulation with Stx1 and incubation at 37°C in the presence of 5% CO2. In a
separate set of experiments, cells were treated with Stx1 for 24 h in RPMI 1640
medium containing 0.5% FBS in the presence or absence of anti-human TNF-
antibody (0.01 g/ml), anti-human TNFR1 antibody (5.0 g/ml), or rhTNF- (40
ng/ml). To measure cytotoxicity, 25 l of a 3-(4,5-dimethyl-thiazol-2-yl)-2,5-
diphenyl-tetrazolium bromide (MTT) solution was added to each well and in-
cubated at 37°C in the presence of 5% CO2 for 2 h. At the end of the incubation
period, the microtiter plates were centrifuged at 260  g for 5 min. The super-
natants were removed, and 100 l of lysis buffer (20% SDS, 50% 2,2 dimethyl-
formamide [pH 4.7]) was added to each well. The plates were incubated at 37°C
without CO2 for 3 h. Cell lysis was measured by determining the optical density
at 570 nm (OD570) with an automated microtiter plate reader (Dynatech
MR5000; Molecular Dynamics, Chantilly, VA). The percentage of apoptosis was
determined using the following equation: percentage of apoptosis 	 [(average
OD570 of treated cells 
 average OD570 of control cells)/average OD570 of
control cells]  100.
In previous studies we used the MTT assay, annexin V/propidium iodide
staining, and terminal deoxynucleotidyl transferase-mediated dUTP nick-end
labeling (TUNEL) staining to show that the results were closely correlated; that
is, the majority of Stx1-induced cell death detected by MTT is apoptotic cell
death (7).
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Analysis of apoptosis by annexin V and propidium iodide staining. Apoptosis
of nonadherent monocytic THP-1 cells was evaluated by measuring the percent-
age of annexin V-positive (annexin V) propidium iodide-positive (PI) cells.
Monocytic THP-1 cells were pretreated with each inhibitor for 1 h, and Stx1 in
RPMI 1640 medium containing 0.5% FBS was added for 6 h. Cells were washed
with cold PBS, stained with annexin V-fluorescein isothiocyanate, and then
incubated with propidium iodide for 15 min at room temperature using an
annexin V-FLUOS staining kit (Roche Diagnostics Corp., Indianapolis, IN).
Cells were centrifuged, washed twice in incubation buffer, and suspended in 0.5
ml of incubation buffer. Cells were analyzed by flow cytometry with gating for
annexin V and PI cells. Total apoptosis was expressed as follows: (% of
annexin V cells  % of annexin V PI cells) 
 the background fluorescence.
Analysis of apoptosis by the TUNEL assay. To detect the presence of apop-
totic adherent macrophage-like THP-1 cells, the TUNEL assay was performed
using an in situ cell death detection kit with fluorescein (Roche). TUNEL
staining was performed in accordance with the protocol provided by the manu-
facturer. Briefly, macrophage-like THP-1 cells (2 105 cells/well) were plated on
16-well Lab-Tek chamber slides (Nalge-Nunc International, Naperville, IL).
Cells were treated with Stx1 in RPMI 1640 medium containing 0.5% FBS in the
presence or absence of caspase-1, -2, -3, -6, -8, or -9 inhibitors (all at a concen-
tration of 40 M) for 24 h. Following the inhibitor treatments, media were
removed and cells were fixed in freshly prepared 4% paraformaldehyde for 1 h
at room temperature. Cells were rinsed with PBS and incubated with permeabi-
lization solution (0.1% Triton X-100 in 0.1% sodium citrate) for 2 min on ice.
After washing, the labeling reaction (TUNEL reaction mixture and a 1:10 mix-
ture of enzyme solution to label solution) was performed for 1 h in a humidified
atmosphere at 37°C in the dark. After 1 h, slides were washed with PBS, and
labeled DNA fragments were visualized using fluorescence microscopy. The
percentage of apoptosis was calculated by using the following equation: percent-
age of apoptosis 	 (number of TUNEL-positive cells treated with Stx1 plus
inhibitor/number of TUNEL-positive Stx1-treated cells)  100.
Preparation of cellular lysates and Western blot analysis. Prior to Stx1 stim-
ulation, THP-1 cells (5  106 cells/well) were washed twice in cold PBS, and
RPMI 1640 medium with 0.5% FBS was added to reduce endogenous kinase
activity. Cells were pretreated with caspase, NF-B, JNK, or p38 inhibitors for
1 h and stimulated with Stx1. After various times, cells were washed with PBS
and suspended with modified radioimmunoprecipitation assay buffer (1.0% Non-
idet P-40, 1.0% sodium deoxycholate, 150 mM NaCl, 50 mM Tris-HCl [pH 7.5],
0.25 mM sodium pyrophosphate, 2.0 mM sodium vanadate, 2.0 mM sodium
fluoride, 10 g/ml aprotinin, 1.0 g/ml leupeptin, 1.0 g/ml pepstatin, 200 mM
phenylmethylsulfonyl fluoride) at 4°C. Cellular lysates were centrifuged at 10,000
 g for 10 min, and supernatants were collected for the Western blot assay. To
measure cytochrome c release from mitochondria, cytosolic and mitochondrial
fractions were collected using a mitochondrion isolation kit for tissues (Pierce,
Rockford, IL). Equal amounts of proteins (60 to 80 g protein per gel lane) were
separated by 8% or 12% Tris-glycine SDS-PAGE and transferred to nitrocellu-
lose membranes. The membranes were blocked with 5% milk prepared with
TBST (20 mM Tris [pH 7.6], 137 mM NaCl, 0.1% Tween 20). The membranes
were incubated with primary antibodies for 24 h at 4°C. After washing, the
membranes were incubated with secondary antibodies (horseradish peroxidase-
labeled anti-rabbit or anti-mouse antibodies) for 2 h at room temperature. Bands
were visualized using the Western Lightning chemiluminescence system (NEN-
Perkins Elmer, Boston, MA). The data shown below are the data from at least
two independent experiments.
Measurement of changes in the mitochondrial membrane potential. Mito-
chondrial membrane potential (m) detection kits (Stratagene, La Jolla, CA)
were used to detect alterations in the transmembrane potential. Differentiated
THP-1 cells (5  106 cells/well) were treated with Stx1 for 24 h. After stimula-
tion, cells were detached by treatment with Accutase (Innovative Cell Technol-
ogies Inc., San Diego, CA) for 10 min. After centrifugation at 260  g for 5 min,
supernatants were removed, and cells were washed in ice-cold PBS and resus-
pended in 0.5 ml JC-1 assay buffer containing the reagent 5,5,6,6-tetrachloro-
1,1,3,3-tetraethylbenz-imidazolocarbocyanine iodine (JC-1). Cells were incu-
bated for 15 min at 37°C in the presence of 5% CO2, centrifuged at 400  g for
5 min, and washed twice in JC-1 assay buffer. JC-1 fluorescence associated with
mitochondrial membranes was detected using flow cytometry.
Measurement of caspase activity. Caspase activation was measured with the
colorimetric substrates for caspase-1 (YVAD-p-nitroanilide), caspase-2 (Ac-
VDQQD-p-nitroanilide), caspase-3 (Ac-DEVD-p-nitroanilide), caspase-6 (VEID-
p-nitroanilide; Biovision, Mountain View, CA), caspase-8 (Ac-IETD-p-nitroanilide),
and caspase-9 (Ac-LEHD-p-nitroanilide; Chemicon, Temecula, CA) used according
to the manufacturers’ recommendations. Briefly, differentiated THP-1 cells (5 106
cells/well) were stimulated with Stx1 in the presence or absence of inhibitors for
various times. Cell lysates were prepared, and protein concentrations in the super-
natants were determined using a Bio-Rad Dc protein assay kit (Bio-Rad, Hercules,
CA). Equal amounts of proteins were incubated for 2 h at 37°C with the colorimetric
substrates for caspase-1, caspase-2, caspase-3, caspse-6, caspase-8, and caspase-9.
The results were determined spectrophotometrically at 405 nm with a microtiter
plate reader. Caspase activity was expressed as picomoles of p-nitroanilide liberated
per minute per microgram of protein.
Statistical analysis. Significance was determined by Student’s t test (Excel;
Microsoft Corp., Redmond, WA).
RESULTS
Role of TNFRs and TNF- in Stx1-mediated killing of mac-
rophage-like THP-1 cells. We previously showed that undiffer-
entiated, monocyte-like THP-1 cells express the toxin-binding
glycolipid Gb3 and are sensitive to apoptosis induction by
purified Stx1. In the undifferentiated state, the cells did not
express mTNF-, TNFR1, or TNFR2 and were refractory to
apoptosis induction by exogenously added rhTNF- (17).
These data suggested that Stxs induce apoptosis in monocytic
cells via a TNFR/TNF--independent mechanism. In contrast,
differentiated macrophage-like THP-1 cells expressed lower
levels of membrane Gb3 and were less sensitive to apoptosis
induction but secreted soluble TNF- when they were stimu-
lated with Stx1. To investigate the role of TNF- in apoptosis
induction of macrophage-like cells, we examined the expres-
sion of TNFR1, TNFR2, and mTNF- by FACS analysis (Fig.
1A). Differentiated THP-1 cells expressed both TNFRs and
mTNF-. Treatment of the cells with purified Stx1 did not alter
TNFR or mTNF- expression (data not shown). Following
exposure to Stx1 (400 ng/ml) for 24 h, approximately 30% of
THP-1 cells died (Fig. 1B). Treatment of cells with an equiv-
alent dose of an enzymatically inactive Stx1 toxoid (Stx1A
)
failed to trigger cell death. We have shown previously that
purified Stx1 B subunits failed to induce apoptosis in differen-
tiated THP-1 cells (7). Together, these data suggest that bind-
ing and intracellular routing of functional toxin are necessary
for signaling leading to cell death in macrophage-like cells.
Despite expression of TNFRs, addition of rhTNF- (40 ng/ml)
to the cells did not result in apoptosis at 24 h. Prior to use of
rhTNF- in these experiments, we verified the cytokine bio-
logical activity using the actinomycin D-treated L929 cytotox-
icity assay. However, if the cells were simultaneously treated
with Stx1 and exogenous rhTNF- for 24 h, apoptosis was
significantly increased compared to the apoptosis observed
after treatment with Stx1 alone (P  0.01). To investigate
whether TNF- elicited from Stx1-treated cells enhanced ap-
optosis, we added neutralizing antibodies directed against
TNFR1 or TNF- to macrophage-like THP-1 cells for 1 h prior
to a 24-h treatment with purified Stx1. Neither TNFR1- nor
TNF--neutralizing antibodies inhibited Stx1-induced apopto-
sis (Fig. 1B). Prior to use of the antibodies in these experi-
ments, we verified the neutralizing activity using rhTNF- in
the actinomycin D-treated L929 cytotoxicity assay. Treatment
of cells with TNFR1- or TNF--neutralizing antibodies alone
did not affect cell viability. These data suggest that even though
macrophage-like THP-1 cells express TNFRs and mTNF-
and Stx1 induces soluble TNF- synthesis or release from the
cells (34), apoptosis following exposure to purified Stx1 occurs
through a mechanism independent of TNFR/TNF- interac-
tion. However, macrophage-like cells respond differently to
VOL. 75, 2007 Stx1-INDUCED SIGNALING FOR APOPTOSIS AND CELL SURVIVAL 1293
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
simultaneous challenge with two potentially proapoptotic mol-
ecules (Stx1 and TNF-) than to challenge with either stimu-
lant alone.
Stx1 triggers caspase activation in macrophage-like THP-1
cells. Activated cysteine-dependent aspartate-specific pro-
teases (caspases) are key mediators of programmed cell death.
In previous studies, we showed that Stx1-induced apoptosis of
macrophage-like THP-1 cells was blocked by the general
caspase inhibitor ZVAD-fmk (7). To further investigate
caspase activation, we examined the extent and kinetics of
activation of caspase-1 (also known as interleukin-1-convert-
ing enzyme), initiator caspases (caspase-2, caspase-8, and
caspase-9), and executioner caspases (caspase-3 and caspase-6)
isolated from THP-1 cells treated with Stx1 for 8 h. With the
exception of caspase-1, increases in all caspase activities were
detected, with caspase-3 and caspase-6 showing the highest
activity and maximal induction (Table 1). We also used the
TUNEL assay to show that pretreatment of cells with individ-
ual specific caspase inhibitors (caspase-1, -2, -3, -6, -8, and -9
inhibitors) for 1 h before Stx1 treatment for 24 h blocked
Stx1-induced apoptosis in macrophage-like THP-1 cells to
some extent, with the caspase-3 and -9 inhibitors resulting in
the greatest percentage of reduction in apoptosis compared to
control cells (Table 1). We detected minimal caspase-1 activa-
tion by Stx1, and blocking caspase-1 activity resulted in modest
(29.9%) inhibition of Stx1-induced apoptosis. Stx1 induced a
twofold increase in caspase-2 activity, but a caspase-2 inhibitor
also failed to significantly reduce toxin-mediated cell killing.
To correlate caspase functional activity with activation, we
FIG. 1. Role of TNF- and TNFR in Stx1-induced apoptosis of macrophage-like THP-1 cells. (A) After differentiation, cells were fixed and
incubated with fluorescein-conjugated anti-TNFR1, anti-TNFR2, anti-mTNF-, or control mouse IgG antibody. Fluorescence was measured by
flow cytometry. The data from at least two independent experiments are shown in representative histograms. (B) Macrophage-like THP-1 cells
were treated with or without neutralizing anti-TNFR1 or anti-TNF- antibodies for 1 h and then treated with Stx1 (400 ng/ml), Stx 1A
 enzymatic
mutant (400 ng/ml), rhTNF- (40 ng/ml), or Stx1 plus rhTNF- for 24 h. Apoptosis was measured by the MTT assay. The percentage of apoptosis
was calculated based on the formula described in Materials and Methods. The data are means  standard errors of the means from three
independent experiments. An asterisk indicates a significant difference (P  0.01) compared to Stx1-treated cells.
TABLE 1. Measurement of caspase activities and effect of caspase
inhibitors on Stx1-induced apoptosis of macrophage-like
THP-1 cells
Caspase
Caspase activity (pmol/min/g
protein)
% Inhibition of apoptosis
in the presence of
specific caspase inhibitorcControla Stx1 treated (8 h)b
Caspase-1 2.5  0.1 3.0  0.3 (1.2) 29.9  8.8
Caspase-2 4.4  0.2 8.7  0.3 (2.0) 30.9  4.7
Caspase-3 5.4  0.1 13.2  0.4 (2.4) 46.7  11.6
Caspase-6 4.5  0.4 10.9  0.5 (2.4) 41.4  16
Caspase-8 4.9  0.4 8.3  0.8 (1.7) 41.0  10.5
Caspase-9 3.9  0.4 7.0  1.0 (1.8) 51.2  12.9
a The control was not treated with Stx1.
b The numbers in parentheses indicate fold induction.
c Determined by the TUNEL assay. The level of apoptosis in the absence of
inhibitor was 100%.
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examined the cleavage of procaspase-3, procaspase-8, and pro-
caspase-9 by Western blot analysis (Fig. 2). Cleavage of pro-
caspases was first observed 4 h after toxin treatment. The
maximal caspase-3 and -8 levels occurred 8 h after Stx1 treat-
ment, while the caspase-9 levels peaked 10 h after Stx1 treat-
ment. These data suggest that in both monocytes (17) and
macrophage-like cells, caspase-1 and caspase-2 are not major
signaling molecules in Stx1-induced apoptosis. Stx1 appears to
activate similar patterns of caspases in monocytic and macro-
phage-like THP-1 cells. Inhibitor studies suggested that in
monocytic cells, caspase-3 and caspase-8 play major roles in
apoptosis (17), while caspase-3, caspase-6, caspase-8, and
caspase-9 appear to contribute to macrophage apoptosis.
Stx1 activates the mitochondrial pathway of apoptosis in a
fraction of macrophage-like THP-1 cells. The intrinsic pathway
of apoptosis is induced by the proapoptotic Bcl-2 family of
proteins. Active Bcl-2 proteins translocate to mitochondrial
membranes and release cytochrome c from mitochondria into
the cytoplasm by disruption of the mitochondrial membrane
potential (8). Following cytochrome c release, the apoptosome
is formed, leading to recruitment and activation of caspase-9
(18). We previously showed that treatment of monocytic
THP-1 cells with Stx1 resulted in cleavage of Bid, a proapop-
totic BH3 domain-only member of the Bcl-2 family, within 4 h
of toxin treatment, followed by the release of cytochrome c
(17). To investigate whether apoptosis of a fraction of macro-
phage-like THP-1 cells was triggered through the intrinsic
pathway, we examined Bid cleavage, m, and cytochrome c
release over time following exposure to Stx1. We detected late
activation of Bid in cytosolic fractions, which was first noted
after 12 h of toxin treatment in macrophage-like THP-1 cells
(Fig. 3A). To ensure that truncated Bid was associated with
mitochondria, we showed that after 24 h of incubation with
Stx1, the cytosolic Bid levels were significantly decreased, while
we detected increased concentrations of Bid in mitochondrial
fractions (Fig. 3A). Release of mitochondrial stores of cyto-
chrome c lagged behind Bid activation, and only trace quanti-
ties of cytochrome c were detected in the cytosol 12 h after Stx1
treatment (Fig. 3A). However, Stx1 significantly increased cy-
tochrome c release from mitochondria to the cytoplasm com-
pared to the release in untreated control cells after 24 h of
toxin treatment, as shown by an increase in the cytosolic levels
along with a concomitant reduction in the concentrations of
cytochrome c in mitochondrial fractions. To measure m,
THP-1 cells were incubated for 24 h with Stx1, separated into
nonadherent, adherent, and total (nonadherent plus adherent)
fractions, and stained with the fluorescent mitochondrial mem-
brane binding agent JC-1 (Fig. 3B). We predicted that apop-
totic cells would detach from plastic surfaces and become sus-
pended, while live cells would remain adherent. As predicted,
in the nonadherent fraction, m (determined from the per-
centage of cells maintaining mitochondrial membrane-associ-
ated fluorescence) was significantly decreased (only 38.2% 
5.4% of the cells maintained the mitochondrial membrane
potential) compared to the results for control untreated cells
(80.2%  2.5%), while a modest m value was obtained for
the adherent fraction (69.8%  2.1%). The percentage of cells
maintaining a normal mitochondrial membrane potential in the
total fraction of Stx1-treated cells was intermediate (57.6% 
5.4%) between the values for the nonadherent and adherent
fractions. Taken together, these data suggest that Stx1 triggers
apoptosis by the intrinsic pathway in a fraction of macrophage-
FIG. 2. Caspase cleavage in macrophage-like THP-1 cells treated
with Stx1. Macrophage-like THP-1 cells were treated with Stx1 (400
ng/ml) for various times. Cells were collected, washed with PBS, and
lysed. Total protein concentrations were determined, and equal
amounts of total protein (60 to 80 g) were separated by 12% Tris-
glycine SDS-PAGE. Caspase-3, -8, and -9 cleavage was detected using
caspase-specific antibodies. Actin was included as a control for protein
loading. The immunoblots are representative immunoblots from three
independent experiments.
FIG. 3. Bid translocation, cytochrome c release, and loss of m in
Stx1-treated THP-1 cells. (A) Macrophage-like THP-1 cells were in-
cubated for different times with Stx1 (400 ng/ml). Cytosolic and mito-
chondrial fractions were prepared as described in Materials and Meth-
ods. Bid and cytochrome c were visualized by Western blotting (WB)
using Bid- or cytochrome c-specific antibodies. The immunoblots are
representative immunoblots from at least two separate experiments.
(B) THP-1 cells were treated with Stx1 (400 ng/ml) for 24 h. After
incubation, total, adherent, or nonadherent cells were collected, and
JC-1 was used to measure m by flow cytometry. Control cells were
maintained in medium for 24 h. The data are the means  standard
errors of three independent experiments.
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like THP-1 cells through Bid activation, disruption of the mito-
chondrial membrane potential, and cytochrome c release. The
kinetics of intrinsic pathway activation in macrophage-like cells
are slower than the kinetics in Stx1-sensitive monocytic THP-1
cells (17).
Roles of NF-B and MAPKs in Stx1-induced apoptosis and
cell survival. Stx1 rapidly activates the transcriptional factor
NF-B in human peripheral blood monocytes and macro-
phage-like cells (34). NF-B has been shown to be an impor-
tant antiapoptotic signaling molecule in response to various
stimuli. To determine if NF-B activation is involved in cell
survival, macrophage-like cells were pretreated with the
NF-B inhibitor PDTC for 1 h prior to treatment with Stx1 for
24 h. As shown in Fig. 4A, apoptosis in response to toxin
treatment was significantly increased (up to 70%) in the face of
NF-B inhibition. Treatment of macrophage-like cells with
Stx1 also resulted in activation of the JNK and p38 MAPK
cascades (3). To examine the role of these pathways in cell
death or survival, we blocked JNK and p38 activation 1 h
before toxin treatment using specific inhibitors and measured
apoptosis following exposure of cells to Stx1. Macrophage ap-
optosis was modestly but significantly (P  0.01) increased in
the face of JNK inhibition, while blocking p38 phosphorylation
resulted in decreased apoptosis (P  0.01) (Fig. 4A). Stx1
rapidly induced nuclear localization of NF-B and p38 activa-
tion in macrophage-like THP-1 cells, starting at 30 min and 2 h,
respectively, after toxin stimulation (3, 34). Based on these
data, we hypothesized that rapid NF-B and MAPK activation
are necessary for cell survival and apoptotic signaling. To ad-
dress this hypothesis, macrophage-like THP-1 cells were
treated with NF-B, JNK, or p38 inhibitors 4 h after Stx1
treatment, and after 24 h of incubation, apoptosis was mea-
sured. Compared to cells treated with toxin alone, we did not
detect significant differences in the percentages of apoptosis
for cells treated with PDTC or the p38 inhibitor 4 h after toxin
treatment (Fig. 4A), suggesting that NF-B and p38 MAPK
must be activated within a 4-h time frame to have their pro-
tective and proapoptotic effects, respectively. In contrast, the
levels of apoptosis were significantly increased compared to
the levels with toxin treatment alone (P  0.01) in cells pre- or
posttreated with the JNK inhibitor, suggesting that long-term
activation of the JNK MAPK cascade may be necessary for
antiapoptotic signaling.
In contrast to the results obtained with macrophage-like
cells, NF-B and JNK and p38 MAPKs were not extensively
activated by Stx1 treatment of monocytic THP-1 cells (data not
shown), and NF-B, JNK, and p38 inhibitor pretreatment did
not significantly alter monocyte apoptosis in response to Stx1
(Fig. 4B). Collectively, these data suggest that NF-B and JNK
trigger survival pathways in macrophages, while the p38
MAPK cascade may be involved in signaling for apoptosis.
Neither NF-B nor the MAPKs appear to be involved in Stx1-
induced apoptosis of undifferentiated THP-1 cells.
Effect of caspase inhibitors on Stx1-induced NF-B and
MAPK activation. Having shown that caspases are activated in
Stx1-treated macrophage-like cells, we tested whether JNK
and p38 MAPK pathways are upstream regulators of caspase
activation. Cells were pretreated with inhibitors specific for
caspase-3, caspase-8, and caspase-9 and the general caspase
inhibitor ZVAD-fmk for 1 h, followed by incubation with pu-
rified Stx1 for 4 h. Cells were then harvested and lysates were
prepared for examination of JNK and p38 activation. As shown
in Fig. 5, JNK phosphorylation occurred in the presence of
caspase-3, -8, and -9 inhibitors, but surprisingly, pretreatment
of cells with ZVAD-fmk resulted in a substantial decrease in
JNK activation in response to Stx1 exposure. Activation of p38
was not affected by any of the caspase inhibitors. These data
suggest that JNK and p38 are upstream signaling pathways
involved in the regulation of Stx1-induced caspase activation.
Effect of NF-B and MAPK inhibition on Stx1-induced
caspase activation. Since Stx1 triggers NF-B, MAPK, and
caspase activation in macrophage-like THP-1 cells, we exam-
ined the effects of NF-B, JNK, and p38 inhibitors on caspase
activation. Cells were pretreated with inhibitors for 1 h and
then incubated with Stx1 for an additional 8 h. We observed
significantly increased (P  0.01) caspase-3 and -8 activities in
cells pretreated with PDTC or the JNK inhibitor (Fig. 6). In
FIG. 4. Comparison of Stx1-induced apoptosis and survival signal-
ing factors in monocytic and macrophage-like THP-1 cells. (A) Mac-
rophage-like THP-1 cells were treated with Stx1 alone (400 ng/ml) or
with inhibitors of NF-B (50 M PDTC), JNK (50 M SP600125)
(JNK In.), and p38 (20 M SB203580) (p38 In.) 1 h before (solid bars)
or 4 h after (open bars) Stx1 treatment. After inhibitor treatment, cells
were incubated for 24 h, and apoptosis was measured by the MTT
assay. The data are means  standard errors of the means from three
independent experiments. An asterisk indicates a significant difference
(P  0.01). (B) Monocytic THP-1 cells were pretreated with NF-B
(50 M PDTC), JNK (50 M SP600125) (JNK In.), and p38 (20 M
SB203580) (p38 In.) inhibitors for 1 h prior to Stx1 (400 ng/ml) treat-
ment. Monocytic THP-1 cells were incubated with Stx1 for 6 h, stained
with annexin V and propidium iodide, and analyzed by flow cytometry
to determine the relative percentages of apoptosis.
1296 LEE ET AL. INFECT. IMMUN.
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
contrast, inhibition of p38 signaling resulted in slight, but sta-
tistically insignificant, decreases in caspase-3 and -8 activation
in response to Stx1 treatment. We did not detect significant
differences in caspase-9 activity in cells treated with the NF-B
or JNK inhibitor and Stx1, whereas cells pretreated with the
p38 inhibitor showed significant decreases in caspase-9 activity
(P  0.02). Cells treated with inhibitors alone showed basal
(unstimulated control) levels of caspase activities. These data
suggest that in response to Stx1 treatment, NF-B and JNK
may be involved in the negative regulation of caspase-3 and -8
activation, while the p38 MAPK cascade may mediate pro-
apoptotic signaling through regulating increased caspase-9 ac-
tivity.
Role of IAPs in Stx1-induced apoptosis and survival signal-
ing pathways. IAPs share conserved polypeptide domains, and
their ectopic expression protects recipient cells from apoptosis
induced by viral infection, TNF-, DNA-damaging agents, or
growth factor withdrawal (4). We observed different patterns
of IAP expression and degradation in monocytic and macro-
phage-like THP-1 cells treated with Stx1. In macrophage-like
cells, the IAP-1 levels rapidly increased after toxin stimulation,
peaking at a 1.5-fold increase 4 h after toxin treatment (Fig.
7A). IAP-2 was constitutively expressed in Stx1-treated mac-
rophage-like cells (Fig. 7B). In contrast, IAP-1 and IAP-2 were
almost completely degraded at 12 and 24 h, respectively, in
Stx1-treated monocytic THP-1 cells. In macrophage-like cells,
XIAP expression increased beginning 4 h after toxin treatment
and peaked at 6 h with a 1.7-fold increase (Fig. 7C). XIAP
appeared to be degraded 24 h after toxin treatment. In mono-
cytic cells, XIAP degradation began 6 h after toxin treatment.
Thus, in macrophage-like cells, Stx1 simultaneously triggers
apoptotic signaling through caspase activation (Table 1) and
transient activation or constitutive expression of proteins in-
volved in cell survival. In monocytic cells, which are highly
sensitive to killing by Stxs, caspases are activated while IAPs
are degraded.
Role of protein synthesis inhibition and the ribotoxic stress
response in cell death and survival. We previously showed that
Stx1 and anisomycin treatment of differentiated THP-1 cells
caused a transient increase in total protein synthesis, followed
by a decline (3). To ensure that CHX also mediates protein
synthesis inhibition in macrophage-like cells, we monitored the
incorporation of 3[H]leucine into nascent polypeptides after
CHX treatment. We did not detect a transient increase in total
protein synthesis in CHX-treated cells; rather, protein synthe-
sis rapidly decreased 1 h after CHX treatment to 8 to 9% of the
control levels and for 10 h remained at 3 to 4% of control
values (data not shown). We treated THP-1 cells with the three
protein synthesis inhibitors for 24 h, and cell killing was mea-
sured by the MTT assay. As shown in Fig. 8A, treatment with
CHX at concentrations of 10 and 100 M resulted in signifi-
cantly less cell death than Stx1 treatment (19.6%  3.7% and
29.2% 5.5%, respectively, compared with 49.2% 15%; P
0.01), while anisomycin (0.07, 1.0, and 10 g/ml) effectively
induced cell death (51.6%  3.1%, 86.3%  0.5%, and 87.2%
 0.1%, respectively). We compared the time courses of JNK
and p38 activation in response to treatment with the three
protein synthesis inhibitors. As shown in Fig. 8B, JNK activa-
tion was induced at 1 h and rapidly declined after 2 h of
treatment with CHX (10 M). Similar to the JNK activation
results, phospho-p38 was detected after 1 h of CHX treatment,
and the level slowly decreased thereafter. In marked contrast,
anisomycin and Stx1 triggered prolonged activation of JNK
and p38 MAPK cascades. These data suggest that the simul-
taneous activation of apoptotic and survival signaling in mac-
FIG. 5. Effects of caspase inhibitors on activation of JNK and p38.
Macrophage-like THP-1 cells were treated with specific caspase-3
(C3I), caspase-8 (C8I), and caspase-9 (C9I) inhibitors (all at a con-
centration of 40 M) or the general caspase inhibitor ZVAD-fmk
(zVAD) (50 M) for 1 h. After inhibitor treatment, cells were treated
with Stx1 (400 ng/ml) for 4 h. Cells were then collected and lysed. Cell
lysates were subjected to Western blotting using phospho-JNK or
phospho-p38 specific antibodies. Membranes were stripped and re-
probed with antibodies recognizing both activated and nonactivated
JNK and p38 to verify equal protein loading. The control results are
the results for no inhibitor and Stx1 treatment. The immunoblot shown
is representative of the results of two independent experiments.
FIG. 6. Stx1 induced caspase activation in cells pretreated with
NF-B or MAPK inhibitors. Macrophage-like THP-1 cells were
treated with NF-B (50 M PDTC), JNK (50 M SP600125) (JNK
In.), and p38 (20 M SB203580) (p38 In.) inhibitors prior to Stx1 (400
ng/ml) treatment. Cells were incubated for 8 h, and caspase-3, -8, and
-9 activities were analyzed using specific colorimetric substrates as
described in Materials and Methods. The control data are the data for
no inhibitor and Stx1 treatment. The data are means standard errors
of the means from three independent experiments. One, two, and
three asterisks indicate significant differences (P 0.001, P 0.01, and
P  0.02, respectively) for comparisons with Stx1-treated cells.
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rophage-like cells is not associated with protein synthesis inhi-
bition per se but is correlated with prolonged activation of JNK
and p38 MAPKs.
DISCUSSION
In this study, we investigated the bases for the cell matura-
tion-dependent differences in THP-1 cell responses to Stx1
(Table 2). Monocytic THP-1 cells grow in suspension, replicate
with a characteristic doubling time, express membrane Gb3,
and are sensitive to killing by Stx1 so that 83.7% of cells
undergo apoptosis within 12 h of toxin exposure. We failed to
detect TNFR and mTNF- expression by monocytic cells using
FACS analysis (17). Thus, our data suggested that Stx1-in-
duced apoptosis of monocytic THP-1 cells does not require
TNF-/TNFR1 ligation. Differentiation to the mature, macro-
phage-like state is accompanied by a cessation of replication,
adherence to plastic with the development of pseudopodia,
increased phagocytic activity, modest increases in membrane
CD14 expression, and decreases in Gb3 expression. The re-
duction in toxin receptor expression that we have observed in
differentiated THP-1 cells may contribute to the relative resis-
tance to Stx1-mediated apoptosis since fewer toxin molecules
may be internalized by the cells. In addition, both cell survival
and apoptotic signaling pathways may be activated by the toxin
in macrophages. As was the case with undifferentiated cells,
FIG. 7. Comparison of IAP-1, IAP-2, and XIAP expression in Stx1-treated macrophage-like and monocytic THP-1 cells. Both macrophage-like
and monocytic THP-1 cells were treated for different times with Stx1 (400 ng/ml). After stimulation, cells were lysed, and equal amounts of total
proteins were separated by 8% Tris-glycine SDS-PAGE. For detection of IAP-1 (A), IAP-2 (B), and XIAP (C) by Western blotting (WB),
IAP-specific antibodies were used. Based on the relative mobility of IAP-2 in HeLa cell lysates, IAP-2 is the lower band in panel B. The levels of
IAP-1, IAP-2, and XIAP were determined by densitometric scanning and compared to the control levels (left panels). The right panels show
representative immunoblots from at least two separate experiments. A representative immunoblot for actin is shown at the bottom as a control
for protein loading.
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neither purified Stx1 B subunits (7) nor an enzymatically inac-
tive Stx1 toxoid was capable of triggering cell death in differ-
entiated THP-1 cells. Macrophage-like THP-1 cells become
competent to rapidly express or release proinflammatory cyto-
kines, including TNF-, on exposure to Stx1 (31). Xaus et al.
(48) reported that lipopolysaccharide (LPS)-induced apoptosis
in macrophages was mediated by TNF- acting through
TNFR1 in an autocrine manner. TNFR1 comprises part of a
death receptor, and when TNFR1 is bound to TNF-, apop-
tosis may be triggered through a caspase-8-dependent mecha-
nism (24). Based on these data, we hypothesized that Stx1 may
trigger macrophage apoptosis, in part, through the production
or release of soluble TNF-. However, compared to the results
obtained with monocytic cells, the induction of apoptosis in
Stx1-treated macrophages was delayed and diminished so that
only 10.7% of the cells displayed an apoptotic phenotype 12 h
after toxin exposure (7). We demonstrate here that THP-1 cell
differentiation is associated with increased TNFR and
mTNF- expression. However, pretreatment of the cells with
neutralizing anti-TNF- or anti-TNFR1 antibodies failed to
alter apoptosis mediated by Stx1. Thus, macrophage-like
THP-1 cells express both the ligand and receptor capable of
inducing apoptosis, yet apoptosis occurs in only a fraction of
cells treated with Stx1.
Addition of exogenous TNF- failed to mediate apoptosis in
either monocytic (17) or macrophage-like cells. Macrophages
appear to utilize protective mechanisms mediated, in part,
through NF-B activation to disrupt TNF- proapoptotic sig-
naling (1). We have previously shown that Stx1 rapidly triggers
the nuclear translocation of NF-B (p50/p65 heterodimer) in
macrophage-like THP-1 cells (34). Human blood monocyte-
derived macrophages treated with PDTC are highly sensitive
to TNF--mediated apoptosis (21), as are cells derived from
mice deficient in upstream NF-B activators (19). Expression
of a number of apoptosis inhibitors, including members of the
Bcl-2 family and IAPs, are regulated by NF-B (14). We pre-
viously noted, however, that simultaneous treatment of mac-
rophage-like THP-1 cells with Stx1 and LPS resulted in the
rapid onset of apoptosis, with approximately 75% of the ap-
optosis occurring within 12 h (7). Here we found that simul-
taneous treatment of cells with purified Stx1 and rhTNF- also
slightly increased apoptosis. Collectively, our findings suggest
FIG. 8. Anisomycin and Stx1 trigger prolonged activation of JNK and p38 MAPKs in macrophage-like THP-1 cells. (A) Cells were incubated
with cycloheximide (10 and 100 M), anisomycin (Aniso) (70 ng/ml, 1.0 g/ml, and 10 g/ml), or Stx1 (400 ng/ml) for 24 h. Cell death was measured
by the MTT assay. The data are means  standard errors of the means from three independent experiments. One and two asterisks indicate
significant (P  0.01) decreases and increases, respectively, compared to Stx1-treated cells. (B) Cells were incubated with CHX (10 M),
anisomycin (1.0 g/ml), or Stx1 (400 ng/ml) for different times. After cells were lysed, equal amounts of total proteins were separated by 8%
SDS–PAGE and subjected to Western blotting with antibodies specific for phospho-JNK or phospho-p38. Blots were stripped and reprobed with
antibodies recognizing total JNK or p38. The results are representative of two independent experiments.
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that TNF- alone does not induce apoptosis in differentiated
THP-1 cells. However, even though Stx1 rapidly activates
NF-B signaling cascades, in the face of protein synthesis in-
hibition, macrophages may not be capable of mounting the
compensatory antiapoptotic response triggered by exogenous
TNF- and/or bacterial products that elicit TNF- production.
In monocytic cells, Stx1 appeared to activate caspase-3,
caspase-6, caspase-8, and caspase-9, and inhibitor studies sug-
gested that caspase-3 and caspase-8 are the major caspases
involved in apoptosis (17). Stx1 activated the intrinsic pathway
of apoptosis induction, triggering Bid cleavage, mitochondrial
membrane disruption, and cytochrome c release 4 h after toxin
exposure We show here that this broad array of caspases and
the intrinsic pathway of apoptotic signaling were also activated
by Stx1 in macrophage-like THP-1 cells, although the kinetics
of Bid activation and cytochrome c release were delayed com-
pared to the results obtained for monocytic cells (Table 2). We
reasoned that if the intrinsic pathway was important in Stx1-
induced macrophage apoptosis, then nonadherent cells should
have an increased loss of mitochondrial membrane potential
compared to viable cells remaining plastic adherent, and we
found that this indeed was the case. These data suggest that
macrophage-like THP-1 cells possess functional apoptotic sig-
naling mechanisms leading to caspase activation and mito-
chondrial membrane perturbation, yet only a fraction of cells
undergo apoptosis after exposure to Stx1.
We and other workers have shown that Stx1 activates the
stress-activated JNK and p38 protein kinase cascades (3, 12,
37). While NF-B has been reported to be involved in cell
survival signaling, JNK and p38 MAPK cascades may be asso-
ciated with cell survival or apoptosis pathways depending on
the cell type (47). We used inhibitors of these signaling mole-
cules to examine their role in cell death and survival. Inhibition
of NF-B and JNK signaling resulted in increased macrophage
apoptosis following exposure to Stx1, while pretreatment with
the p38 inhibitor reduced cell killing. To more directly link
NF-B, JNK, and p38 signaling pathways with caspase activa-
tion, we examined Stx1-mediated caspase-3, -8, and -9 activa-
tion in cells treated with NF-B, JNK, and p38 inhibitors.
Inhibition of NF-B and JNK significantly increased caspase-3
and -8 activity, while p38 inhibition caused a significant decline
in caspase-9 activity. Recent studies using primary human
monocytes showed that LPS signaling through Toll-like recep-
tor 4 leads to NF-B activation and inhibition of caspase-8
activity. LPS induced apoptosis through caspase-8 activation
only when NF-B signaling was blocked (23). In contrast to
LPS, Stx1 activates both NF-B and caspase 8 in differentiated
THP-1 cells, yet the majority of cells survive intoxication. We
pretreated cells with caspase-3, -8, and -9 inhibitors prior to
Stx1 exposure to show that the JNK and p38 MAPK pathways
are activated upstream of caspase activation. However, the
general caspase inhibitor ZVAD-fmk blocked Stx1-induced
JNK activation through a mechanism that remains to be ex-
plored. Finally, we found that the anti- and proapoptotic ef-
fects of NF-B and p38, respectively, probably require rapid
activation of these signaling molecules, as delaying inhibitor
treatment for as short a time as 4 h after toxin treatment failed
to alter the percentage of apoptosis. In contrast, the antiapop-
totic effects of JNK involve slower or prolonged activation, as
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apoptosis was significantly increased even when the JNK in-
hibitor was added 4 h after Stx1 exposure.
Antiapoptotic factors that may be regulated by NF-B and
the MAPK pathways remain to be fully explored, but the mu-
rine genes encoding IAP-1 and IAP-2 are known to be differ-
entially regulated by NF-B and p38 (29). The IAPs are a
family of antiapoptotic proteins characterized by the presence
of zinc-binding baculovirus IAP repeat elements (BIR). BIR
are essential for direct IAP binding to caspases (35). In addi-
tion to possessing three tandem BIR, IAP-1 and IAP-2 also act
as E3 ubiquitin ligases, transferring the 76-amino-acid ubiq-
uitin moiety from ubiquitin-conjugating enzymes to target pro-
teins. Ubiquitinated proteins are subjected to proteasome-me-
diated degradation. The target proteins of IAP-1 and IAP-2
ubiquitination include caspase-3, and caspase-7 (10), the ap-
optosis regulatory protein SMAC (9, 36), and the NF-B sig-
naling molecules IKK and RIP (30, 40). Unique among the
IAP family proteins, IAP-1 and IAP-2 associate with the cyto-
solic TNFR2 adaptor proteins TRAF-1 and TRAF-2 (33). We
show here that IAP-1 and IAP-2 are degraded in Stx1-treated
monocytic THP-1 cells, which rapidly undergo apoptosis (Ta-
ble 2). In macrophage-like cells, IAP-1 expression is transiently
upregulated in response to Stx1, while IAP-2 appears to be
constitutively expressed. The maintenance of IAP-1 and -2
expression in Stx1-treated macrophages may result in caspase
inactivation, in disruption of apoptotic signaling, and in in-
creased TRAF-1 and -2 ubiquitination leading to disruption of
TNFR-mediated signaling. XIAP, known to be an inhibitor of
caspase-3, -7, and -9 activity (20), was rapidly degraded in
Stx1-treated monocytes. The levels of XIAP gradually declined
over a 24-h period after Stx1 treatment of macrophage-like
cells and did not return to basal levels, as was the case with
IAP-1 and 2.
We showed that the protein synthesis inhibitors Stx1, aniso-
mycin, and CHX all reduced total protein synthesis in differ-
entiated THP-1 cells, although the kinetics of inhibition dif-
fered. Stx1 and anisomycin triggered a transient increase in
protein synthesis lasting 4 to 6 h after intoxication, followed by
a decline in protein synthesis (3). We failed to detect a tran-
sient increase in protein synthetic activity in CHX-treated cells.
Although the three reagents blocked protein synthesis, CHX
did not effectively induce cell death, so that protein synthesis
inhibition per se was not required for apoptosis in the time
frame examined in this study. However, the capacity to induce
the ribotoxic stress response, as defined by prolonged activa-
tion of the JNK and p38 MAPK cascades, did correlate with
the ability of Stx1 and anisomycin to simultaneously trigger cell
survival and apoptotic signaling pathways.
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